Exact Mass: 383.1191

Exact Mass Matches: 383.1191

Found 68 metabolites which its exact mass value is equals to given mass value 383.1191, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Acutumidine

Dauricumidine

C18H22ClNO6 (383.1136)


   

Atropine methobromide

Hyoscyamine methylbromide

C18H26BrNO3 (383.1096)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics Atropine methyl bromide, a muscarinic receptor (mAChR) antagonist, is a quaternary ammonium salt of atropine and a mydriatic for dilation of the pupil during ophthalmic examination. It is introduced for relieving pyloric spasm in infants for its highly polar nature. It penetrates less readily into the central nervous system than atropine[1][2].

   

2-Naphthalenecarboxamide, 3-hydroxy-N-(2-methoxy-3-dibenzofuranyl)-

3-Hydroxy-N-{4-methoxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2,4,6,9,11-hexaen-5-yl}naphthalene-2-carboximidate

C24H17NO4 (383.1158)


   

Dragmacidonamine A

Dragmacidonamine A

C19H19N4O3S (383.1178)


   

MCULE-2715920117

MCULE-2715920117

C19H17N3O6 (383.1117)


   

N-(2,3-Dihydro-1H-indol-1-ylcarbothioyl)-5-(2-phenylethynyl)nicotinamide

N-(2,3-Dihydro-1H-indol-1-ylcarbothioyl)-5-(2-phenylethynyl)nicotinamide

C23H17N3OS (383.1092)


   

MCULE-1441994257

MCULE-1441994257

C19H17N3O6 (383.1117)


   
   

hydracyanoside F

hydracyanoside F

C17H21NO9 (383.1216)


   

Lycogaric acid A

Lycogaric acid A

C23H17N3O3 (383.127)


   

1-acetyl-12-glutamyl-beta-carboline-3-carboxylate|dichotomine H|N-[(1-acetyl-9H-beta-carbolin-3-yl)carbonyl]-L-glutamic acid|tunicoidine B

1-acetyl-12-glutamyl-beta-carboline-3-carboxylate|dichotomine H|N-[(1-acetyl-9H-beta-carbolin-3-yl)carbonyl]-L-glutamic acid|tunicoidine B

C19H17N3O6 (383.1117)


   
   
   
   
   
   

2-[[1-(4-nitrobenzoyl)pyrrolidine-2-carbonyl]amino]benzoic acid

2-[[1-(4-nitrobenzoyl)pyrrolidine-2-carbonyl]amino]benzoic acid

C19H17N3O6 (383.1117)


   
   

Amoxicillin(hydrolyzed form)

Amoxicillin(hydrolyzed form)

C16H21N3O6S (383.1151)


   
   
   
   
   
   
   

Ala-Trp-OH

(S)-3-(1H-indol-3-yl)-2-(3-methoxy-4-nitrobenzamido)propanoic acid

C19H17N3O6 (383.1117)


   

Trp-Gly-OH

2-(3-(2-(1H-indol-3-yl)ethoxy)-4-nitrobenzamido)acetic acid

C19H17N3O6 (383.1117)


   

2-{[1-(4-Nitrobenzoyl)prolyl]amino}benzoic acid

2-{[1-(4-Nitrobenzoyl)prolyl]amino}benzoic acid

C19H17N3O6 (383.1117)


   

4-PYRIDIN-4-YL-4,5,6,7-TETRAHYDRO-3H-IMIDAZO-[4,5-C]PYRIDINE

4-PYRIDIN-4-YL-4,5,6,7-TETRAHYDRO-3H-IMIDAZO-[4,5-C]PYRIDINE

C21H21NO4S (383.1191)


   

(2S,5R)-Benzhydryl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide

(2S,5R)-Benzhydryl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide

C21H21NO4S (383.1191)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(3-BROMO-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(3-BROMO-PHENYL)-ETHYL]-PYRROLIDINE

C17H26BrN3O2 (383.1208)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(4-BROMO-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(4-BROMO-PHENYL)-ETHYL]-PYRROLIDINE

C17H26BrN3O2 (383.1208)


   

LY320135

4-(6-Methoxy-2-(4-methoxyphenyl)benzofuran-3-carbonyl)benzonitrile

C24H17NO4 (383.1158)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063387 - Cannabinoid Receptor Antagonists

   

tert-Butyl 4-(4-bromo-3,5-dimethylphenoxy)piperidine-1-carboxylate

tert-Butyl 4-(4-bromo-3,5-dimethylphenoxy)piperidine-1-carboxylate

C18H26BrNO3 (383.1096)


   

methyl 1-[(2-cyanobiphenyl-4-yl)methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-7-carboxylate

methyl 1-[(2-cyanobiphenyl-4-yl)methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-7-carboxylate

C23H17N3O3 (383.127)


   

(R)-(+)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE

(R)-(+)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE

C14H19FeN 10* (383.1143)


   

(S)-(-)-N-(1-PHENYLETHYL)SUCCINAMICACID

(S)-(-)-N-(1-PHENYLETHYL)SUCCINAMICACID

C14H19FeN 10* (383.1143)


   

Amoxycilloic Acid (Mixture of Diastereomers)

Amoxycilloic Acid (Mixture of Diastereomers)

C16H21N3O6S (383.1151)


   

4-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-TETRAHYDRO-THIOPYRAN-4-CARBOXYLIC ACID

4-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-TETRAHYDRO-THIOPYRAN-4-CARBOXYLIC ACID

C21H21NO4S (383.1191)


   

(S)-ETHYL4-BENZYL-5-OXO-MORPHOLINE-3-CARBOXYLATE

(S)-ETHYL4-BENZYL-5-OXO-MORPHOLINE-3-CARBOXYLATE

C21H21NO4S (383.1191)


   

S-tubercidinylhomocysteine

S-tubercidinylhomocysteine

C15H21N5O5S (383.1263)


   
   

(S)-7-(5-S-(3-amino-3-carboxypropyl)-5-thio-beta-D-ribofuranosyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine

(S)-7-(5-S-(3-amino-3-carboxypropyl)-5-thio-beta-D-ribofuranosyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine

C15H21N5O5S (383.1263)


   

Amoxicilloic acid

Amoxicilloic acid

C16H21N3O6S (383.1151)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Phe-Asp-Cys

Phe-Asp-Cys

C16H21N3O6S (383.1151)


A tripeptide composed of L-phenylalanine, L-aspartic acid, and L-cysteine joined by peptide linkages.

   

7-(difluoromethyl)-N-(5-methyl-1,2-oxazol-3-yl)-5-(4-methylphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

7-(difluoromethyl)-N-(5-methyl-1,2-oxazol-3-yl)-5-(4-methylphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

C19H15F2N5O2 (383.1194)


   

S-adenosyl-L-homocysteinate

S-adenosyl-L-homocysteinate

C14H19N6O5S- (383.1138)


A L-alpha-amino acid anion obtained by deprotonation of S-adenosyl-L-homocysteine. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

4-[[Oxo-[2-(2-pyridinyl)-4-quinolinyl]methyl]amino]benzoic acid methyl ester

4-[[Oxo-[2-(2-pyridinyl)-4-quinolinyl]methyl]amino]benzoic acid methyl ester

C23H17N3O3 (383.127)


   

N-(1,3-benzodioxol-5-yl)-6-methyl-2-(2-pyridinyl)-4-quinolinecarboxamide

N-(1,3-benzodioxol-5-yl)-6-methyl-2-(2-pyridinyl)-4-quinolinecarboxamide

C23H17N3O3 (383.127)


   

2-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-(3-ethylphenyl)-3-hydroxy-5-nitro-4-triazolimine

2-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-(3-ethylphenyl)-3-hydroxy-5-nitro-4-triazolimine

C18H17N5O5 (383.123)


   

3-[5-(2,5-Dimethyl-1-phenyl-3-pyrrolyl)-1,3,4-oxadiazol-2-yl]-1-benzopyran-2-one

3-[5-(2,5-Dimethyl-1-phenyl-3-pyrrolyl)-1,3,4-oxadiazol-2-yl]-1-benzopyran-2-one

C23H17N3O3 (383.127)


   

3-Pyridin-2-yl-2-(4-quinolin-4-ylphenyl)-1,3-thiazolidin-4-one

3-Pyridin-2-yl-2-(4-quinolin-4-ylphenyl)-1,3-thiazolidin-4-one

C23H17N3OS (383.1092)


   
   
   
   
   
   

2-[(4E)-4-[[1-(3-ethoxycarbonylphenyl)pyrrol-2-yl]methylidene]-2,5-dioxoimidazolidin-1-yl]acetic acid

2-[(4E)-4-[[1-(3-ethoxycarbonylphenyl)pyrrol-2-yl]methylidene]-2,5-dioxoimidazolidin-1-yl]acetic acid

C19H17N3O6 (383.1117)


   

H-DL-nTyr-Gly(Unk)-OH

H-DL-nTyr-Gly(Unk)-OH

C16H21N3O6S (383.1151)


   

atropine methyl bromide

Hyoscyamine methylbromide

C18H26BrNO3 (383.1096)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics Atropine methyl bromide, a muscarinic receptor (mAChR) antagonist, is a quaternary ammonium salt of atropine and a mydriatic for dilation of the pupil during ophthalmic examination. It is introduced for relieving pyloric spasm in infants for its highly polar nature. It penetrates less readily into the central nervous system than atropine[1][2].

   

6-[2-(1,4-dihydroxypentyl)-1,3-thiazol-4-yl]-3-hydroxy-4,5-dimethoxypyridine-2-carboximidic acid

6-[2-(1,4-dihydroxypentyl)-1,3-thiazol-4-yl]-3-hydroxy-4,5-dimethoxypyridine-2-carboximidic acid

C16H21N3O6S (383.1151)


   

8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C18H22ClNO6 (383.1136)


   

5-ethenyl-1-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyran-3-carbonitrile

5-ethenyl-1-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyran-3-carbonitrile

C17H21NO9 (383.1216)


   

(1r,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(1r,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C18H22ClNO6 (383.1136)


   

(1s,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(1s,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C18H22ClNO6 (383.1136)


   

4-({3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}methyl)-1,3-dimethyl-5-(methylsulfanyl)-2h-imidazol-2-yl

4-({3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}methyl)-1,3-dimethyl-5-(methylsulfanyl)-2h-imidazol-2-yl

C19H19N4O3S (383.1178)


   

(3s,4as,5r,6s)-5-ethenyl-1-oxo-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyran-3-carbonitrile

(3s,4as,5r,6s)-5-ethenyl-1-oxo-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyran-3-carbonitrile

C17H21NO9 (383.1216)


   

(3s)-3-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-3-{[(1r)-1-carboxy-2-sulfanylethyl]-c-hydroxycarbonimidoyl}propanoic acid

(3s)-3-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-3-{[(1r)-1-carboxy-2-sulfanylethyl]-c-hydroxycarbonimidoyl}propanoic acid

C16H21N3O6S (383.1151)